NHS National Framework for Transition products commencing 1 February 2025

Award

Buyers

Value

£6

Suppliers

Classifications

Pharmaceutical products

Published

2 months ago

Description

Project title: NHS National Framework for Transition products commencing 1 February 2025<br/>Offer reference number: CM/TNS/24/5713<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection<br/><br/>Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

Contract Agreement

The official contract terms, conditions, and scopes of work.

Download
Award Notice

Details on the tender award and selected suppliers.

Download